A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
Clinical trial NCT06517758 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06517758
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2027-04-30
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.